Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573579
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest Hospital NHS Foundation TrustNot Yet RecruitingNot Applicable
NCT07573579Not Yet Recruiting
Not Applicable
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest...
NCT07572084
Romiplostim N01 in Chemoradiotherapy-induced Aplastic AnemiaPeking Union Medical College HospitalNot Yet RecruitingPhase 2
NCT07572084Not Yet Recruiting
Phase 2
Romiplostim N01 in Chemoradiotherapy-induced Aplastic AnemiaPeking Union Medical Coll...
NCT07572786
Effect of Electroacupuncture on Bowel Function and Quality of Life in Postpartum Constipation: A Randomized Controlled TrialMTI UniversityNot Yet RecruitingNot Applicable
NCT07572786Not Yet Recruiting
Not Applicable
Effect of Electroacupuncture on Bowel Function and Quality of Life in Postpartum...MTI University
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07573683
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive IndividualsFoundation University IslamabadRecruitingNot Applicable
NCT07573683Recruiting
Not Applicable
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary...Foundation University Isl...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07574294
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca TrevigianaCompleted
NCT07574294Completed
—
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca Trev...
NCT07572656
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe PreeclampsiaMuhammad Aamir LatifCompletedNot Applicable
NCT07572656Completed
Not Applicable
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preecl...Muhammad Aamir Latif
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLCNot Yet RecruitingPhase 1
NCT07572006Not Yet Recruiting
Phase 1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Develo...
NCT07572058
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLCNot Yet RecruitingNot Applicable
NCT07572058Not Yet Recruiting
Not Applicable
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLC
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07573046
Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic DisordersHospices Civils de LyonNot Yet Recruiting
NCT07573046Not Yet Recruiting
—
Validation Study of the ExéSem Battery Designed to Differentiate the Contributio...Hospices Civils de Lyon
NCT07573020
Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone LossMansoura UniversityCompletedNot Applicable
NCT07573020Completed
Not Applicable
Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and M...Mansoura University
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573618
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration Versus Standard AnticoagulationWeiwei WuNot Yet RecruitingNot Applicable
NCT07573618Not Yet Recruiting
Not Applicable
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration V...Weiwei Wu
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed3 (15%)
not_applicable12 (60%)
Phase 23 (15%)
Not Specified3 (15%)
Phase 12 (10%)